CDK6 and glioblastoma: In addition, it reduces the migration of tumors by targeting CDK6 [21] GBM cells like U87MG and T98G, which have a high expression of the clock circadian regulator (CLOCK) gene; this plays a vital role in maintaining tumorigenesis.